Eine Übersicht aller Sessions/Sitzungen dieser Tagung.
Bitte wählen Sie einen Ort oder ein Datum aus, um nur die betreffenden Sitzungen anzuzeigen oder eine einzelne Sitzung um die gegebenenfalls vorhandenen Abstracts einsehen zu können.
|
Sitzungsübersicht |
Datum: Donnerstag, 06.02.2025 | |
10:30 - 12:00 |
Career Workshop: The importance of a network for your scientific career Ort: Saal B Chair: Claudia Göttsch, TU Dresden, Deutschland Chair: Holger Winkels, Universität zu Köln, Deutschland |
12:00 - 12:30 |
Presidents Opening Ort: Saal B Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland Chair: Oliver Weingärtner, Universitätsklinikum Jena, Deutschland |
12:30 - 13:15 |
Keynote - Panagiotis Deloukas Ort: Saal B Chair: Winfried März, Synlab Holding Deutschland GmbH, Deutschland Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland Genetic Risk Scores Oueen Mary University of London, London, Vereinigtes Königreich |
13:15 - 13:30 |
Break / Exhibition / Industry Symposium 13:15 - 14:20 Ort: Foyer |
13:30 - 14:20 |
Kardiovaskuläre Prävention – Zeit zu handeln! - presented by Amgen Ort: Saal B Chair: Tienush Rassaf, Universitätsklinikum Essen, Deutschland Kardiovaskuläre Prävention – wo stehen wir in Deutschland? Universitätsklinikum Essen, Essen, Deutschland Erfolgreiche Integration des Lipidmanagements – Wie wichtig sind funktionierende Versorgungsstrukturen? Praxis für Prävention und kardiovaskuläre Medizin, Essen, Deutschland Lp(a) – ein unterschätzter Risikofaktor für kardiovaskuläre Erkrankungen? Universitätsklinikum Köln (AöR), Köln, Deutschland |
14:20 - 16:00 |
Inherited metabolic disorders Ort: Saal B Chair: Stefan R. Bornstein, Universitätsklinikum Carl Gustav Carus, Deutschland Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland The polygenic nature of hypertriglyceridemia Medical Faculty Mannheim at the University of Heidelberg, Mannheim Genetics of LDL-C- and Lp(a) metabolism Deutsches Herzzentrum München, München, Deutschland Genetics (and Epigenetics) of Diabetes Mellitus Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, Nuthetal, Deutschland Genetics of adiposity Universitätsklinikum Essen, Essen, Deutschland |
16:00 - 16:15 |
Break and Exhibition 16:00 - 17:00 Ort: Foyer |
16:15 - 17:00 |
Neueste Fortschritte in der medikamentösen Behandlung von Adipositas bei kardiologischen Patienten – presented by Novo Nordisk Ort: Saal B Chair: Shibu Mathew, Universitätsmedizin Essen, Deutschland GLP-1 RA – Eine feste Säule in der kardiovaskulären Prävention? Universitätsklinikum Freiburg, Freiburg, Deutschland |
17:00 - 18:40 |
Young Investigator Award Session Ort: Saal B Chair: Karsten Grote, Philipps-Universität Marburg, Deutschland Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland Longitudinal Assessment of Sub-clinical Arterial Inflammation in Patients Receiving Immune-Checkpoint Inhibitors by Sequential [18F]FDG PET Scans Uniklinik Freiburg, Freiburg, Germany Hyperinsulinemia promotes atherosclerosis by inducing metabolic reprogramming of autoreactive CD4+ T cells 1: La Jolla Institute for Immunology, La Jolla, CA, USA; 2: Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 3: Immunology Center of Georgia (IMMCG), Augusta University, Augusta, GA, USA; 4: Carter Immunology Center, University of Virginia, Charlottesville, VA, United States; 5: Cardiovascular Research Center, University of Virginia, Charlottesville, VA, United States; 6: Division of Cardiovascular Medicine/Department of Medicine, University of Virginia, Charlottesville, VA, United States Adenosine deaminase acting on RNA-2 (ADAR2) controls atherosclerosis progression in mice and humans 1: Department of Cardiovascular Research, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; 2: Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; 3: Department of Clinical Therapeutics, National and Kapodistrian University of Athens Medical School, Athens, Greece. Bidirectional crosstalk between macrophages and the heart: drivers of function and dysfunction post-injury. 1: Universitätsklinikum Freiburg, Freiburg, Germany; 2: Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg-Bad Krozingen, Germany; 3: Institute for Disease Modelling and Targeted Medicine (IMITATE), University Clinic Freiburg, Germany; 4: Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany Intestinal leukocytes regulate cardiac remodeling after myocardial infarction 1: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (Medizinische Klinik I), Uniklinik RWTH Aachen, Aachen, Deutschland; 2: Klinik für Pneumologie und Internistische Intensivmedizin (Medizinische Klinik V), Uniklinik RWTH Aachen, Aachen, Deutschland; 3: Klinik für Gastroenterologie, Stoffwechselerkrankungen und Internistische Intensivmedizin (Medizinische Klinik III), Uniklinik RWTH Aachen, Aachen, Deutschland; 4: Klinik für Kinder- und Jugendmedizin, Uniklinik RWTH Aachen, Aachen, Deutschland; 5: Department III of Internal Medicine, Heart Center, University Hospital of Cologne Accumulation of gut-derived metabolite phenylacetylglutamine in chronic kidney disease promotes cardiac remodeling and is associated with cardiovascular and overall mortality 1: Uniklinik RWTH Aachen, Department of Cardiology, Angiology and Critical Care (Medical Clinic 1), Aachen, Germany; 2: Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; 3: Department of Nephrology and Kidney Transplantation, University Hospitals Leuven, Leuven, Belgium; 4: Uniklinik RWTH Aachen, Interdisciplinary Center for Clinical Research (IZKF) Genomics Facility, Aachen, Germany Characterization of IFNIC macrophages as potential therapeutic target in experimental aneurysm using scRNA- and CITE-sequencing 1: Division for Cardiology, Pulmonology and Vascular Medicine, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 2: Genomics and Transcriptomics Laboratory, Biologisch-Medizinisches-Forschungszentrum (BMFZ), Heinrich-Heine University Düsseldorf, Germany; 3: Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 4: Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany |
18:40 - 21:00 |
Poster Session with "Wine & Cheese" Ort: Foyer Chair: Yvonne Döring, Universitätsspital Bern, Schweiz Chair: Michael Torzewski, Robert-Bosch-Krankenhaus GmbH, Deutschland Chair: Dennis Wolf, Uniklinik Freiburg, Deutschland Chair: Andreas Zirlik, Medizinische Universität Graz, Österreich C-reactive protein and cardiovascular risk in 454,203 individuals without ASCVD 1: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (Medizinische Klinik I), Uniklinik RWTH Aachen, Aachen, Deutschland; 2: Klinik für Gastroenterologie, Stoffwechselerkrankungen und Internistische Intensivmedizin (Medizinische Klinik III), Uniklinik RWTH Aachen, Aachen, Deutschland; 3: Klinik für Gefäßchirurgie, Uniklinik RWTH Aachen, Aachen, Deutschland Characterizing the leukocyte diversity of the arterial vasculature in healthy mice by nuclear and single-cell RNA sequencing University Hospital Freiburg, Freiburg im Breisgau, Deutschland CKD triggers enhanced cardiac dysfunction, inflammation and metabolic alterations after myocardial infarction 1: Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, Germany; 2: Department of Internal Medicine I, Cardiology, Uniklinik RWTH Aachen, Aachen, Germany; 3: Department of Translational Research, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Germany; 4: Institute of Pathology, Uniklinik RWTH Aachen, Aachen, Germany Comparative Effects of Nano/Microparticles on NF-κB Activation: Implications for Inflammation Beyond Microplastics Cardiology and Angiology, Philipps-University Marburg, Germany Effect of Myocardial Infarction on the immune response in the melanoma tumor immune microenvironment 1: Department III of Internal Medicine, Heart Center, University Hospital, University of Cologne, Cologne, Germany; 2: Center for Molecular Medicine Cologne, Cologne, Germany; 3: Institute of Experimental Oncology, University of Bonn, Bonn, Germany Exposure to dietary α-amylase-trypsin inhibitors (ATI) induces vascular inflammation and endothelial dysfunction 1: Laboratory for Molecular Cardiology, University Hospital Mainz, Germany; 2: Institute of Translational Immunology, University Hospital Mainz, Germany; 3: Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany Hypercholesterolemia triggers innate immune imbalance and transforms brain infarcts after stroke 1: Institute of Experimental Immunology and Imaging, University of Duisburg-Essen, Essen, Germany; 2: Leibniz-Institut für Analytische Wissenschaften - ISAS -e.V., Dortmund, Germany; 3: Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany Inhibition of B cell activation by Ibrutinib improves cardiac function in experimental myocardial infarction in mice University Heart Centre Freiburg-Bad Krozingen, Medical Centre, University of Freiburg, Germany Kynurenine predicts outcome in pulmonary infections with a link to cardiac dysfunction 1: Uniklinik RWTH Aachen, Medizinische Klinik 1, Aachen, Deutschland; 2: Uniklinik RWTH Aachen, Medizinische Klinik 5, Aachen, Deutschland; 3: Uniklinik RWTH Aachen, Medizinische Klinik 3, Aachen, Deutschland; 4: Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; 5: Uniklinik RWTH Aachen, Institut für Pathologie, RWTH centralized Biomaterial Bank, Aachen, Deutschland Ligature-induced Periodontitis Alters Hematopoiesis and Aggravates Atherosclerotic Plaque Formation in Mice 1: University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany; 2: Center of Cardiovascular Medicine (CCM ABCD) – Aachen, Bonn, Cologne, Düsseldorf; 3: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 4: Polyclinic for Operative Dentistry and Periodontology, Faculty of Medicine and University Hospital Cologne; 5: Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Gießen Liver fat content predicts cardiovascular events in 39,953 individuals without ASCVD 1: Department of Internal Medicine I – Cardiology, Angiology and Internal Intensive Care Medicine, University Hospital RWTH Aachen, Germany; 2: Department of Medicine III – Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Germany; 3: Medical Department 1, Technische Universität Dresden, Germany; 4: The Institute for Translational Medicine and Therapeutics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA Mex3a protects against atherosclerosis: evidence from mice and humans. 1: Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany; 2: German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Germany; 3: Institute for Genetic and Biomedical Research, Unit of Milan, National Research Council, Italy Neutrophils Extracellular Traps Myeloperoxidase and Elastase Predict Cerebral Vasospasms after Aneurysmal Subarachnoid Hemorrhage 1: Department of Oral, Maxillofacial and Facial Plastic Surgery, University Hospital Düsseldorf, Düsseldorf, Germany; 2: Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Deutschland; 3: Department of Neurology, University Hospital Düsseldorf, Düsseldorf, Germany Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis 1: The first affiliated Hospital of Sun Yat Sen University; 2: Institute for cardiovascular prevention, LMU, Munich Product problems of in vitro diagnostics for differential diagnostics of myocardial infarction and pulmonary embolism – Analysis of field safety notes published by BfArM between 2014 and 2023 1: Pharmazeutisches Institut Universität Bonn, Bonn, Deutschland; 2: Institut für Ernährungswissenschaften, Friedrich-Schiller-Universität Jena; 3: Synlab Akademie, Mannheim Role of complement in adhering platelets and immune cells to endothelium of various organs 1: UMM, Mannheim, Deutschland; 2: Eberhard Karls Universität Tübingen Senolytic Therapy Reduces IL-6-Mediated Inflammation in the Diabetic Heart 1: 1Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 2: Institute for Translational Pharmacology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 3: Molecular Radiooncology Clinic for Radiation Therapy and Radiooncology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany Senolytics restore diabetes-induced aortic dysfunction in DIO mice 1: Division of Cardiology, Pulmonology and Vascular Medicine, Düsseldorf, Deutschland; 2: Institute for Translational Pharmacology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 3: Cardiovascular Research Institute Düsseldorf (CARID), Medical Faculty, Heinrich Heine University, Düsseldorf, Germany; 4: Division of Cardiac Surgery, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Düsseldorf, Germany Sex-related differences of cardiovascular health in a murine model of celiac disease 1: Laboratory for Molecular Cardiology, University Hospital Mainz, Germany; 2: Institute of Translational Immunology, University Hospital Mainz, Germany; 3: Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany T regulatory cells (Tregs) lose their protective phenotype in patients with coronary artery disease (CAD) Universitätsklinikum Freiburg, Freiburg, Germany The Effects of Fasting on Leukocyte Trafficking in Organ Crosstalk 1: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (Medizinische Klinik I), Uniklinik RWTH Aachen, Aachen, Deutschland; 2: Klinik für Nieren- und Hochdruckkrankheiten, Rheumatologische und Immunologische Erkrankungen (Medizinische Klinik II), Uniklinik RWTH Aachen, Aachen, Deutschland; 3: Klinik für Pneumologie und Internistische Intensivmedizin (Medizinische Klinik V), Uniklinik RWTH Aachen, Aachen, Deutschland; 4: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum Halle (Saale), Halle (Saale), Deustchland The human early atherosclerotic lesion: Insights from Technovit® embedding and integrative imaging 1: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany; 2: Department of Laboratory Medicine and Hospital Hygiene, Robert-Bosch-Hospital, 70376 Stuttgart, Germany The Role of Enzymatically Modified LDL (eLDL) and Angiopoietin-like Protein 4 (ANGPTL4) in Aortic Valve Stenosis 1: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP), Stuttgart, Deutschland; 2: Department of Cardiovascular Surgery, Robert-Bosch-Hospital, 70376 Stuttgart, Germany; 3: Department of Laboratory Medicine and Hospital Hygiene, Robert-Bosch-Hospital, 70376 Stuttgart, Germany The role of Fumarate hydratase 1 (Fh1) in foam cell formation 1: University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany; 2: Center of Cardiovascular Medicine (CCM ABCD) – Aachen, Bonn, Cologne, Düsseldorf; 3: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 4: University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute for Metabolomics in Ageing, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany; 5: University of Cologne, Faculty of Mathematics and Natural Sciences, Institute of Genetics, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany Unraveling T regulatory cell instability and protective immunity loss in murine atherosclerosis Vascular Immunology lab, Department of Cardiology and Angiology, University Heart Centre Freiburg-Bad Krozingen, Freiburg, Germany. Lipoprotein (a) and Incident Coronary Heart Disease in the Community: Impact of Traditional Cardiovascular Risk Factors UKE, Hamburg, Hamburg, Deutschland Assessing the role of olfactory receptor 2 in a diet-induced obesity animal model University Hospital Cologne, Cologne, Deutschland |
Datum: Freitag, 07.02.2025 | ||
8:30 - 10:10 |
The life of the atherosclerotic plaque Ort: Saal A Chair: Raluca Mincu, Uniklinikum Essen, Deutschland Chair: Michael Torzewski, Robert-Bosch-Krankenhaus GmbH, Deutschland Cholesterol efflux pathways, vascular function, and atherosclerosis University Medical Center Groningen, AV Groningen, Niederlande Vulnerable atherosclerotic plaques: novel mechanisms and tools to detect them Skåne University Hospital, Lund, Schweden Smooth muscle cells in progressing and regressing atherosclerosis Department of Clinical Medicine, Aarhus University Cellular mechanism of plaque calcification. TU Dresden, Deutschland |
Screening programs for familial hypercholesterolemia Ort: Saal B Chair: Ulrich Paetow, Universitätsklinikum Frankfurt, Deutschland Chair: Anja Vogt, LMU, Medizinische Klinik IV, Deutschland Experiences from the genetic screening program for FH in the Netherlands (1994 to 2014) Amsterdam UMC, , Niederlande FH screening: more than 20 years of experiences in the Czech Republic Charles University, Prague 2, Tschechische Republik FH screening - insights from the VRONI study Deutsches Herzzentrum München, München, Deutschland FH-Screening - pro Nephrologisches Zentrum Göttingen GbR, Göttingen, Deutschland FH-Screening - contra Synlab Holding Deutschland GmbH, Mannheim, Deutschland |
10:10 - 10:30 |
Break and Exhibition 10:10 - 11:15 Ort: Foyer |
|
10:30 - 11:10 |
Lipidversorgung im Fokus: Wo können wir besser werden? A Call for Action - presented by Daiichi Sankyo Ort: Saal B Chair: Christiane Tiefenbacher, MH Wesel, Deutschland Kampagnen für bessere kardiovaskuläre Versorgung Deutsches Herzzentrum München, München, Deutschland Atherosklerose: Früh erkannt - Gefahr gebannt? Kerckhoff-Klinik, Bad Nauheim, Deutschland Nachholbedarf? Lipidmanagement bei PAVK-Patienten University of Duisburg Essen, Essen, Deutschland |
|
11:15 - 12:55 |
Cardiovascular complications of/by atherosclerosis Ort: Saal A Chair: Norbert Gerdes, University Hospital Düsseldorf, Deutschland Chair: Ingo Hilgendorf, Universitätsklinikum Freiburg, Deutschland Cardio-Oncology Universitätsklinikum Essen, Essen, Deutschland Autoimmune mechanisms post-MI Universitätsklinikum Würzburg Endocardium as base of inflammation in MI Universitätsklinikum Heidelberg, Heidelberg, - Clinical imaging of atherosclerosis Deutsches Herzzentrum München, München, Deutschland |
Cardiovascular risk factors - the obvious and the not so obvious Ort: Saal B Chair: Amir Abbas Mahabadi, Universitätsklinikum Essen, Deutschland Chair: Lars Möller, Universitätsklinikum Essen, Deutschland New guidelines for hypertension Universitätsklinikum Marburg, Marburg, Deutschland Local thyroid hormone action revisited - consequences for metabolism and beyond Universitätsklinikum Essen, Essen, Deutschland Microbiome and cardiovascular diseases Universitätsklinikum Essen, Essen, Deutschland The impact of neutrophils on lymphatic microcirculation and post stroke immune suppression. Universitätsklinikum Essen, Essen, Deutschland |
12:55 - 13:30 |
Break and Exhibition 12:55 - 14:20 Ort: Foyer |
|
13:30 - 14:20 |
Strike early and strike strong: Lipidmanagement vor und nach dem Akutereignis - presented by Sanofi Ort: Saal B Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland Prevent The First Event - Herzkreislauf-Erkrankungen vorbeugen Deutsches Herzzentrum München Prevent The Event - PCSK9-Inhibition nach kardiovaskuläremAkutereignis Universitätsklinik Aachen, Aachen, Deutschland |
|
14:20 - 16:00 |
Circadian and oscillatory mechanisms of cardiovascular disease Ort: Saal A Chair: Berkan Kurt, Uniklinik RWTH Aachen, Deutschland Chair: Dennis Wolf, Uniklinik Freiburg, Deutschland Increased inflammation due to microplastics Philipps-Universität Marburg, Marburg, Deutschland New concepts of neutrophil maturation – a matter of location Cells in Motion Interfaculty Centre, Münster, Deutschland What, when and how much to eat for a healthy heart? Friedrich-Schiller-Universität Jena, Jena, Deutschland The effect of food on immune cells in health and disease Uniklinikum Aachen, Aachen, Deutschland |
Emerging risk factors Ort: Saal B Chair: Ioanna Gouni-Berthold, Universitätsklinikum Köln (AöR), Deutschland Chair: Martin Merkel, Endokrinologikum Hamburg, Deutschland APOC3 and ANGPTL3 Medical University of Graz, Graz, Österreich Lipoprotein apheresis in children Universitätsklinikum Köln (AöR), Köln, Deutschland New RNA-based therapies Sulpizio Cardiovascular Center at UC San Diego Health, BSB 1080, La Jolla, CA, 92093-0682, USA Remnants - contra Synlab Holding Deutschland GmbH, Mannheim, Deutschland Remnants - pro University of Copenhagen, Copenhagen, Denmark |
16:00 - 16:15 |
Break and Exhibition 16:00 - 17:00 Ort: Foyer |
|
16:15 - 17:00 |
Kontroversen im lipidologischen Alltag: Genetik und Risikoprävention bei Hypertriglyceridämie - presented by Sobi Ort: Saal B Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland Genetik sHTG: Werden die genetischen Befunde verstanden? Synlab Holding Deutschland GmbH, Mannheim, Deutschland Versorgung: Werden die Triglyceride bei akuter Pankreatitis bestimmt? Privatpraxis, Siegen, Deutschland Therapie: Nutzen der ApoC-III Inhibition bei genetischen und klinischen Risikokonstellationen Universitätsklinikum Dresden, Dresden, Deutschland |
|
17:00 - 18:00 |
Awards Session Ort: Saal B Ehrung für das Lebenswerk Lipidologie durch Verleihung der Chevreul-Medaille der DGFL – Lipid-Liga e. V. an Prof. Dr. Heiner Greten Praxis Dr. Beckenbauer & Dr. Maierhof, Bremen, Deutschland Verleihung der Schönheimer Medaille der DGAF an Prof. Dr. Dr. Christoph Bode Universitätsklinikum Halle, Halle, Deutschland Verleihung des W. H. Hauss-Preis der DGAF an Dr. Hauke Horstmann Universitätsklinikum Halle, Halle, Deutschland Cross-Species Single-Cell RNA Sequencing Decodes Adaptive Immunity in Human and Murine Atherosclerosis NYU Langone Health, New York, USA |
|
18:00 - 19:00 |
DGAF Members assembly Ort: Saal A |
|
19:30 - 22:30 |
Conference Dinner Ort: Rosemarie Garten & Bar |
Datum: Samstag, 08.02.2025 | |
8:45 - 10:55 |
Cellular constituents and mechanisms of the atherosclerotic plaque Ort: Saal B Chair: Sabine Steffens, LMU München, Deutschland Chair: Holger Winkels, Universität zu Köln, Deutschland Atherosclerotic plaque fibroblasts originate from adventitial PDGFRA+ progenitor fibroblasts, and a minority acquires a SMC, or macrophage-like fate in the plaque Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC), Maastricht, The Netherlands The Aryl Hydrocarbon Receptor (AhR) as novel regulator of atherosclerosis Aachen Maastricht Insitute for CardioRenal Disease (AMICARE), Universitätsklinikum Aachen, Aachen, Deutschland Regulation of smooth muscle cells in health and disease Universitäy of Cambridge, Cambridge, Vereinigtes Königreich Immunometabolism in the Vascular Wall: New Opportunities to fight Cardiovascular Diseases University of Southern Denmark - SDU Haematometabolism rewiring in Atherosclerosis C3M Centre Méditerranéen de Médecine Moléculaire, Nice, Frankreich Endothelial cell metabolism European Center for Angioscience, Mannheim, Deutschland |
10:55 - 11:15 |
Break and Exhibition Ort: Foyer |
11:15 - 12:00 |
Seltene Dyslipidämien und ihre diagnostischen und therapeutischen Herausforderungen - presented by Chiesi Ort: Saal B Chair: Anja Vogt, LMU, Medizinische Klinik IV, Deutschland Wenn Fettgewebsverlust zu Hypertriglyceridämie führt - eine Fallvorstellung Auf der Bult, Hannover, Deutschland Seltene Form der familiären Hypercholesterinämie - eine extreme Herausforderung in der Therapie LMU, Medizinische Klinik IV, München, Deutschland |
12:00 - 13:25 |
Geschlecht und kardiovaskuläre Erkrankungen Ort: Saal B Chair: Yvonne Döring, Universitätsspital Bern, Schweiz Chair: Andreas Zirlik, Medizinische Universität Graz, Österreich Verlust des Y-Chromosoms und kardiovaskuläre Ereignisse bei Chronischer Nierenerkrankung Universitätsklinikum Frankfurt, Franfurt a.M., Deutschland Trans-Gender und kardiovaskuläre Erkrankungen Universitätsklinikum Frankfurt, Frankfurt a.M., Deutschland Geschlechterspezifische Aspekte bei KHK und in der Lipidologie Universitätsklinikum Regensburg, Regensburg, Deutschland |
13:25 - 13:45 |
Young Investigator Awards and Closing remarks Ort: Saal B Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland Chair: Oliver Weingärtner, Universitätsklinikum Jena, Deutschland Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland |